Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

Substance Use Disorders Harm Reduction

Concerning reducing the harm caused by substance use disorders.
2024 Regular Session
Health Care & Health Insurance
Bill Summary

Opioid and Other Substance Use Disorders Study Committee. Section 1 of the bill excludes injuries involving the possession of drugs or drug paraphernalia from a physician's mandatory reporting requirements. Sections 2 and 3 clarify that the civil and criminal immunity that protects a person who acts in good faith to furnish or administer an opioid antagonist also protects a person who distributes the opioid antagonist. Section 4 adds an exemption to the prohibition on possessing drug paraphernalia for possession of drug paraphernalia that a person received from an approved syringe exchange program or a program carried out by a harm reduction organization while the person was participating in the program. Section 5 specifies that money appropriated to the department of public health and environment to purchase non-laboratory synthetic opiate detection tests may also be used to purchase other drug testing equipment. Section 6 authorizes an organization operating a clean syringe exchange program to provide drug testing services through the program. Sections 7 though 23 are conforming amendments that update the term "opiate antagonist" to "opioid antagonist".
(Note: This summary applies to this bill as introduced.)


Under Consideration


Bill Text


Sponsor Type Legislators
Prime Sponsor

Rep. E. Epps, Rep. C. deGruy Kennedy
Sen. K. Priola


Rep. M. Young
Sen. S. Jaquez Lewis


Upcoming Schedule

Colorado legislature email addresses ending in are no longer active. Please replace with for Colorado legislature email addresses.  Details